Policlinico Casilino   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Rome Italy (1995)

Organization Overview

First Clinical Trial
2008
NCT01218178
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Policlinico Casilino | Policlinico Casilino ASL RMB